Ebook

    Trends in Biologics Manufacturing from Drug Substance to Fill/Finish

    Trends in Biologics Manufacturing from Drug Substance to Fill/Finish

    November 1 - 30, 2019

    Biopharmaceutical companies and contract manufacturing organizations are investing to increase biomanufacturing and drug product fill-finish capacity in order to keep up with the pace. Fast track approvals, increased focus on orphan diseases and the emergence of personalized medicine are influencing how the industry makes its investment decisions. This ebook examines current and future trends in biologics development and manufacturing and the steps companies are taking to address this changing landscape.

    Biopharma Manufacturing Markets
    Biomanufacturing contract services and supplies markets continue to expand.
    Read More >>

    CEO Spotlight — Catalent
    A conversation with John Chiminski, CEO of Catalent Pharma Solutions.
    Read More >>

    Biopharmaceutical Contract Manufacturing Trends
    Examining the importance of fill-and-finish operations in today's biopharma manufacturing market.
    Read More >>

    Next-Gen Biologics Packaging & Delivery
    As the frontier of drug innovation evolves, so must the design of packaging and delivery systems. Read More >>
    Read More >>